Cencora stock drops as Walgreens volume shift adds revenue pressure

Traders Union
All News
Stocks
Cencora drops 5.63% to $315 today

Highlights

Cencora announced Walgreens will move some volume outside its operations from July 1, reducing near-term revenue contribution.
Fiscal third quarter 2026 revenue of $84.8 billion missed consensus, but adjusted EPS of $4.48 beat forecasts with full-year EPS guidance maintained.
Cencora stock trades below major moving averages with downside momentum prevailing and an expected trading range of $305.39 to $324.77.

Revenue hit as Walgreens volume shifts and topline lags forecasts

Cencora’s disclosure that certain Walgreens volume will move outside its operations beginning July 1, as reported by Investing.com, points to a concrete reduction in sales contribution and directly weighs on near-term revenue prospects. The company reported fiscal third quarter 2026 results with $84.8 billion in revenue missing consensus while adjusted earnings per share of $4.48 exceeded forecasts, according to Barchart, highlighting ongoing topline pressures despite improved profitability. Guidance for full-year fiscal 2026 adjusted EPS was reaffirmed and Cencora noted ongoing growth in GLP-1 product sales and continued capital deployment into investments, M&A, buybacks, and dividends, as discussed on Fool, providing longer-term context as the firm navigates shifting operational volumes.

Bearish momentum as price holds below resistance and sell signals persist

From a technical standpoint, COR is trading below the MA-20 at $325.05, the MA-50 at $319.24, and the longer-term MA-200 at $324.39 on the current working timeframe. The Ichimoku Kijun at $324.52 stands as immediate resistance, while momentum signals such as ADX and Awesome Oscillator remain in Sell mode and MACD has shifted to Neutral. Oscillators including RSI, CCI, and Stoch RSI all show oversold or clear sell conditions, complemented by Bull/Bear Power confirming dominant seller activity. No indicator divergences are apparent across the signal set.

Downside risk prevails amid range-bound volatility and positioning triggers

Over the next few sessions, the expected trading range is between $305.39 and $324.77, with probabilities favoring further downside (63%) versus potential upside (37%). The baseline scenario points to the price staying range-bound between these support and resistance levels. Should COR decisively reclaim $324.52, short covering could accelerate in a bullish scenario, while a move below $305.39 would expose the price to additional downside risk. This range reflects the current volatility band relative to existing levels.

Anton Kharitonov, Traders Union expert, sees ongoing risk in Cencora as structural news flow and price action turn negative. The loss of Walgreens volume, revenue miss, and technical breakdown below vital averages suggest seller control. He remains cautious, with downside more likely unless major resistance is reclaimed. "For now, probabilities still favor further declines — I stay defensive while $324.52 holds as resistance."

Earlier, analysts noted that Cencora shares were experiencing medium-term pressure amid bearish momentum and a prevailing sideways range, as the company remained focused on profitability and strategic investments. The current breakdown below key moving averages and fresh revenue headwinds from Walgreens contract changes add to the bearish case, with a sustained move below $305.39 now representing a critical downside risk for traders to monitor.

Source of Data: COR Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.